Find similar content

Source channel @githubtrending · Post #15212 · Oct 10

#typescript#agent#agent_platform#ai_plugins#chatbot#chatbot_framework#coze#coze_platform#generative_ai#go#kouzi#low_code_ai#multimodel_ai#no_code#rag#studio#typescript#workflow Coze Studio is an easy-to-use, all-in-one platform for building AI agents and apps without needing much coding. It offers visual tools to design, debug, and deploy AI projects quickly using drag-and-drop workflows, plugins, and large language models like GPT-4. You can create smart assistants, chatbots, or custom AI apps with ready templates and manage models, knowledge bases, and plugins in one place. It supports no-code and low-code development, making AI accessible to both beginners and professionals, saving you time and effort in building powerful AI solutions tailored to your needs. It also supports multi-model integration and easy deployment. https://github.com/coze-dev/coze-studio

Hashtags

#typescript #agent #agent_platform #ai_plugins #chatbot #chatbot_framework #coze #coze_platform #generative_ai #go #kouzi #low_code_ai #multimodel_ai #no_code #rag #studio #workflow

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment